Eli Lilly to buy Scorpion Therapeuticsâ cancer drug for $2.5 billion
Eli Lilly and Company will acquire Scorpion Therapeuticsâ investigational cancer drug, currently being evaluated in first- mid-stage trials to treat breast and solid.
Drugs
Health
Medical